STRUCTURE FEATURES AND PHARMACOLOGICAL PROPERTIES OF GERMANIUM(IV) COMPLEXES WITH 1-HYDROXYETHANE-1,1-DIPHOSPHONIC ACID(Review)
№2

Keywords

germanium(IV), 1-hydroxyethane-1,1-diphosphonic (etidronic) acid, nitrogen heterocycles, coordination compounds, biological activity.

How to Cite

Martsynko, O., Seifullina, I., FinikО., & Tsymbaliuk, K. (2024). STRUCTURE FEATURES AND PHARMACOLOGICAL PROPERTIES OF GERMANIUM(IV) COMPLEXES WITH 1-HYDROXYETHANE-1,1-DIPHOSPHONIC ACID(Review). Ukrainian Chemistry Journal, 90(9), 19-30. https://doi.org/10.33609/2708-129X.90.9.2024.19-30

Abstract

 

The review article presents the results of systematic research by the authors of a number of heterometals and mixed-ligand 1-hydroxyethane-1,1-diphosphonatogermanates, their structure, biological and pharmacological properties. It was observed, that hexanuclear cyclic complex anions of the general composition [Ge6(µ-OH)6-n(µ-O)n(µ-hedp)6](6+n)− were present in the aqueous solutions of investigated compounds. At the same time, the composition and charge of the anion in each compound obtained in the solid state depends on the nature of the cation. They all have a common hexameric structure, with germanium atoms connected in pairs by 1-hydroxyethane-1,1-diphosphonate, hydroxo-, or oxo- and hydroxo-bridges. The coordination polyhedron Ge is a curved octahedron with two six-membered GeO2P2C cycles and an eight-membered bimetallic Ge2O4P2 closing, and each ligand performs a tetradentate tris(chelate)-µ-bridging function. The ratio of formed oxo- and hydroxo-bridges and, as a result, the charge of the anion varies under the influence of cation parameters and electrosta­tic interactions. Acute and chronic toxicity studies proved the safety of 1-hydroxyethane-1,1-diphosphonatogermanates. Complexes show a wide spectrum of pharmacological activity: antihypertensive, antiarrhythmic, hepatoprotective, cerebroprotective etc.The pharmacological and biological activities of 1-hydroxyethane-1,1-diphosphonatogermanates(IV) are ensured by the combined action of all biologically active components, which do not compete but show synergistic action. It was concluded that the preparation of new complexes of germanium(IV) with etidronic acid by chemical modification of their composition is a promising area of research in the field of creating coordination compounds with a wide range of pharmacological effects.

https://doi.org/10.33609/2708-129X.90.9.2024.19-30
№2

References

Martsіnko E.E., Seifullina I.I. Design and synthesis of molecular complexes and complexo­nates of germanium(IV) with a wide spectrum of pharmacological action. 2018. Odesa. ONU. (іn Ukranian).

SeifullinaI.I., Martsinko E.E., Afanasenko E.V. Design and synthesis of new homo- and heterometal coordination compounds of germanium(IV) for preparation of low toxic drugs with a wide the rapeuticaction. Visn. Odes. nac. univ., Him. 2015. 20(4): 6–17.

https://doi.org/10.18524/2304-0947.2015. 4(56).56690

Bouhsina S., Buglyó P., AbiAad E., Aboukais A., Kiss T. Formation of oligonuclear complexes between copper(II) and 1-hydroxyethane-­1,1-diphosphonic acid. Inorganica Chim Acta. 2004. 357(1): 305–310.

doi:10.1016/s0020-1693(03)00445-6

Reed W.A., Rao L., Zanonato P., Garnov A.Y., Powell B.A., Nash K.L. Complexation of UVI with 1-Hydroxyethane-1,1-diphosphonic Acidin Acidicto Basic Solutions. Inorg. Chem. 2007. 46(7): 2870–2876.

doi:10.1021/ic0621401

Wang W.N., Sun Z.G., Zhu Y.Y., Dong D.P. et al. Hydrothermal synthesis, structures, and luminescent properties of four new zinc(II) diphosphonate hybrids with mixed ligands. Cryst Eng. Comm. 2011. 13(20): 6099–6106.

doi: 10.1039/C1CE05291H.

Liu B., Ding T., Hua W.J., Liu X.M., Hu H.M., Li S.H., Zheng L.M. Diruthenium(III, III) diphosphonate with a spinground state S = 2. Dalton Trans. 2013. 42(10): 3429–3433.

doi: 10.1039/C2DT32306K

Sun S.H., Sun Z.G., Zhu Y.Y., Dong D.P., Jiao C.Q., Zhu J., Li J., Chu W., Tian H., Zheng M.J., Shao W.Y., Lu Y.F. Four Novel Oxomolybdenum-Organodiphosphonate Hybrids in the Presence of Cu(II)–Organonitrogen Building Blocks: Synthesis, Crystal Structures, and Surface Photovoltage Properties. Cryst. Growth. Des. 2013. 13(11): 226–238.

doi: 10.1021/cg301392p

Liao Z., Ling J., Reinke L., Szymanowski J. Sigmon G., Burns G. Cage clusters built from uranyl ions bridged through peroxo and 1-hydro­xy­ethane-1,1-diphosphonic acid ligands. Dalton Trans. 2013. 42(19): 6793–6799.

doi: 10.1039/c3dt33025g.

Jiao C.Q., Zhao Z., Ma C., Sun Z.G., Dong D.P., Zhu Y.Y., Li J. Chiral and Achiral Copper(II) Carboxyphosphonates Supramolecular Structures: Synthesis, Structures, Surface Photovol­tage, and Magnetic Properties. Cryst. Growth. Des. 2016. 16(10): 5624–5635.

doi: 10.1021/acs.cgd.6b00197.

Ma K.R., Yin J.Z., Hu H., Kan Y.H. Syntheses, Structures and Fluorescent Properties of TwoZn(II)-Diphosphonate Coordination Po­lymers. J Clust. Sci. 2021. 32: 875–886.

doi: 10.1007/s10876-020-01854-z.

Saji H., Ogawa K., Kitamura Y., Kubota-Akizawa M., Kawashima H. Chemical Control of Biological Activity and Biodistribution of Metal Compounds: Drug Design of Metal Complexes with Biological Activity and Target-Specific Biodistribution. Biomed. Res. Trace. Elem. 2007. 18(3): 255–263.

doi: 10.11299/brte.18.255

Campello A., Rodrigues R., Alves F., Miranda K., Brum S., Mdala I., Siqueira J., Rôças I. Enhancing the Intracanal Antibacterial Effects of Sodium Hypochlorite with Etidronic Acidor Citric Acid. J Endodontics. 2022. 48(9): 1161–1168.

doi:10.1016/j.joen.2022.06.006.

Bajpe S., Shetty C., Shetty A., Kaur G., Saji S.A., Prabha C. Scanning electronmicroscopy evaluation of smear layer removal using ethylenediaminetetraacetic acid, etidronic acid, and chitosan nanoparticle solution as root canal irrigants. Endodontology. 2023. 35(1): 48–53.

doi:10.4103/endo.endo_126_22.

Supraja A., Arali V., Rapala H., Vemagiri C., Kallakuri M., Kumar G. Evaluation of Antimicrobial Efficacy of Etidronic Acid against Enterococcus faecalis in Primary Teeth: An In Vivo Study. Intern J Clinical Pediatric Dentistry. 2024. 17(4): 433–436.

doi: 10.5005/jp-journals-10005-2834.

Petriev V.M. Influence of reactant concentrations and solution acidity on the complexation of 188Re with 1-hydroxyethane-1,1-diphospho­nic acid. Radiochemistry. 2008. 50: 203–206.

doi: 10.1134/S1066362208020227.

Martsіnko Е.E. Synthesis, structure and prospects of application of homo- and heterometallic 1-hydroxyethylidenediphosphonateger­ma­nates. Ukr. Chem. J. 2014. 80(8): 88–95. (іn Ukrainian).

Martsynko О.E., Seifullina I.I. Double Ge(IV)-Co(ІІ) complexes with 1-hydroxyethylidenedi phosphonic acid and 2,2′-bipyridine. Vіsn. Odes. Nac. Unіv. Hіm. 2022. 27(1): 31–38.

doi:10.18524/2304-0947.2022.1(81).255828. (іn Ukrainian).

Gudzenko О., Varbanets L., Seifullina I., Mar­tsynko О., Tsymbalyuk K. Мixed-ligand complexes of germanium – 3d-metal with 1-hyd­ro­xyethane-1,1-diphosphonic acidаnd 2,2′-bipyridine as modulators of Bacillussp. IMV B-7883 elastase and fibrinogenase activity. Ukr. Biochem. J. 2024. 96(1): 96–102.

doi:10.15407/ubj96.01.096.

Kresyun V., Seifullina I., Vidavska G., Shemo­naeva K. Prospects for the creation of new drugs based on oxyethylidene diphosphonic acid. Medical chemistry. 2004. 6(3): 133–138. (іn Ukrainian).

Godovan V.V., Kresyun V.Y., Seifullina I.I. Com­parative pharmacological activity of new biologically active substances – derivatives of diphosphonicacids. Integrative anthropology. 2007. 2(10): 13–17. (іn Ukrainian).

Kresyun V., Godovan V.,Seifullina I. Influence of oxyethylidene diphosphonate germanate de­rivatives on the phospholipid composition of membranes in toxic liver damage. J. Aca­demy Med. Sci. Ukraine. 2008. 14(1): 63–71. (іn Ukrainian).

Lukianchuk V., Seifullina I., Litvinenko D., Mar­tsynko O. Pharmacological properties of or­ganic and coordination germanium compounds – modern concepts. Pharmacology and Drug Toxicology. 2016. 1(47): 3–13. (іn Ukrai­nian).

Godovan V.V., Kresyun V.Y., Seifullina I.I. Ti­ssue respiration and oxidative phosphoryla­tio­nin heart mitochondriain experimental myocardial dystrophyandits drug correction. Odes’kij medični jžurnal. 2006. 3(95): 13–17. (іn Ukrainian).

Godovan V.V., Kresyun V.Y., Seifullina I.I. Biologically active antiarrhythmic substance germacord (UA Patent No. 20658). Ukraine. 2007. (іn Ukrainian).

Godovan V.V., Kresyun V.Y., Seifullina I.I. Magnesium oxyethylidene diphosphonato-germanate characterised by vasodilatoraction (UA Patent No. 19965). Ukraine. 2007. (іn Ukrainian).

Lukianchuk V.D., Krylova O.E., Seifullina I.I., Martsynko O.E., Tkachenko V.M. 2-Oxo-­1-pyrrolidinyl acetamide hydroxyethylidene diphosphonate germanate(IV) with cerebroprotective activity (UA Patent No. 45070). Ukraine. 2009. (іn Ukrainian).

Godovan V.V., Kresyun V.Y., Seifullina I.I. Nico­germ - a biologically active hepatoprotective substance (UA Patent No.51482). Ukraine. 2010. (іn Ukrainian).

Lukianchuk V.D., Seifullina I.I., Rysukhina N.V., Martsynko O.E. Method of detoxification of the body in case of endotoxicosis of post-traumatic origin by a complex compound based on germanium, magnesium and oxyethylidenediphosphonic acid (UA Patent No. 36684). Ukraine. 2008. (іn Ukrainian).

Tymchyshyn O.L., Godovan V.V., Seifullina I.I. A cute toxicity of medgerm – a new derivative of germanium salt of diphosphonic acid with copper. Odes’kij medični jžurnal. 2010. 2(118): 23–26. (іn Ukrainian).

Tymchyshyn O.L., Godovan V.V., Kresyun V..Y, Seifullina I.I., Martsynko O.E. Medgerm – a bio­logically active hepatoprotective substance (UAPatent No. 66392). Ukraine. 2011. (іn Uk­rainian).

Downloads

Download data is not yet available.